← Back to Search

Carotenoid

Lutein Supplementation for Eye Strain in Children

N/A
Waitlist Available
Research Sponsored by Northcentral University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age of 8 to 16 years
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test whether lutein supplements can improve cognitive and visual outcomes in children who spend a lot of time looking at screens.

Who is the study for?
This trial is for healthy children aged 8 to 16 who spend at least 4 hours daily on digital screens. They must be in good health overall, as reported by a guardian, and not currently taking supplements with lutein or zeaxanthin.Check my eligibility
What is being tested?
The study tests if taking lutein supplements for six months can improve eye and brain function in kids exposed to lots of screen time. It's a controlled test where some get lutein and others get a placebo without knowing which one they're getting.See study design
What are the potential side effects?
Lutein is generally considered safe but could cause side effects like skin yellowing or stomach pain. Since it's being compared to a placebo, any additional side effects will be closely monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 8 and 16 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Macular Pigment Optical Density - haidinger's brushes
Macular Pigment Optical Density - heterochromatic flicker photometry
Secondary outcome measures
Digital Eye strain change from baseline
Sleep score change from baseline
Verbal Fluency

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: LuteinExperimental Treatment1 Intervention
5 mg lutein gummy taken daily for 180 days
Group II: PlaceboPlacebo Group1 Intervention
0 mg lutein gummy taken daily for 180 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
lutein
2007
N/A
~100

Find a Location

Who is running the clinical trial?

Northcentral UniversityLead Sponsor
Patrick McNamara, PhDStudy ChairNorthcentral University

Media Library

lutein (Carotenoid) Clinical Trial Eligibility Overview. Trial Name: NCT05314647 — N/A
Cognitive Impairment Research Study Groups: Placebo, Lutein
Cognitive Impairment Clinical Trial 2023: lutein Highlights & Side Effects. Trial Name: NCT05314647 — N/A
lutein (Carotenoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05314647 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I be eligible to partake in this trial?

"This research study has 70 slots for applicants aged between 8 to 16 years of age, who have asthenopia and at least 4 hours of daily digital screen usage. Additionally, participants must be certified as generally healthy by their guardian."

Answered by AI

Does this research study accept participants aged 35 or older?

"This study is open to children from 8 years old up until the age of 16."

Answered by AI

Is there availability for participants to join the experiment?

"According to clinicaltrials.gov, the posting for this medical study is no longer active and the trial has not recruited any new patients since April 3rd 2022. However, 330 other trials are actively recruiting volunteers at present."

Answered by AI
~34 spots leftby Apr 2025